FRIDAY, July 22 (HealthDay News) -- For most patients, periorbital rejuvenation with periorbital lipotransfer gives aesthetic improvement, and mild improvement can last for as long as three years, according to a study published in the July/August issue of the Archives of Facial Plastic Surgery.
Cory C. Yeh, M.D., from Yeh Facial Plastic Surgery in Laguna Woods, Calif., and Edwin F. Williams III, M.D., from the Williams Center Plastic Surgery Specialists in Latham, N.Y., investigated the long-term aesthetic results of autologous periorbital lipotransfer in 114 patients. Of these, 99 patients, whose complete photographic and medical records were available during four years, were included in the analysis. Patients were divided into five groups depending on the total length of their postoperative follow-up. A standard aesthetic scale from 0 to 2 (with 0 representing no improvement; 1, mild improvement; and 2, marked improvement) was used by three independent evaluators to assess periorbital volume augmentation. Kappa (κ) correlation was used to assess inter-observer correlation, while statistical significance comparing the same patients in each group was assessed using Mann-Whitney tests.
The investigators found a good correlation in the scores from the three evaluators (κ = 0.316). In almost all patients who had demonstrated improvement for the first three years of follow-up there was aesthetic improvement seen (86.4 percent). The degree of aesthetic improvement decreased each year, and in most patients (68.2 percent) only mild improvement was retained at three-year follow-up (P = 0.049).
"Results from most patients who underwent autologous periorbital lipotransfer demonstrated improvement that lasted as long as three years," the authors write.
Abstract
Full Text (subscription or payment may be required)
